Fuller Bret E, Rieckmann Traci, McCarty Dennis, Smith Kevin W, Levine Helen
Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
J Subst Abuse Treat. 2005 Apr;28(3):273-80. doi: 10.1016/j.jsat.2005.02.003.
Three surveys (1997, 1999, and 2001) of outpatient substance abuse treatment centers in Connecticut, Massachusetts, Rhode Island, Maine, Vermont, and New Hampshire examined organizational characteristics that influenced the adoption of naltrexone. Structural equation modeling with manifest variables assessed predictors related to the use of naltrexone. Use of naltrexone increased over time from 14% in 1997 to 25% in 2001. In 1997, programs funded by managed care were more likely, and clinics that provided only substance abuse services were less likely to use psychiatric medication and naltrexone. In subsequent years, counselor education level and organization size also influenced use of naltrexone.
针对康涅狄格州、马萨诸塞州、罗德岛州、缅因州、佛蒙特州和新罕布什尔州的门诊药物滥用治疗中心开展了三项调查(分别于1997年、1999年和2001年进行),以研究影响纳曲酮采用情况的组织特征。采用带有显变量的结构方程模型评估与纳曲酮使用相关的预测因素。纳曲酮的使用随时间推移有所增加,从1997年的14%增至2001年的25%。1997年,由管理式医疗资助的项目更有可能使用纳曲酮,而仅提供药物滥用服务的诊所使用精神科药物和纳曲酮的可能性较小。在随后几年中,咨询师的教育水平和机构规模也对纳曲酮的使用产生了影响。